Page last updated: 2024-08-17

medroxyprogesterone acetate and Carcinoma, Epidermoid

medroxyprogesterone acetate has been researched along with Carcinoma, Epidermoid in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (44.44)	18.7374
1990's	4 (44.44)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (11.11)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chung, SH; DeMayo, FJ; Lydon, JP; Mehta, FF; Son, J; Yoo, YA	1
Beesley, JE; Croxtall, JD; Gleeson, RP; Guida, L; Jamil, A; Jones, RN; Krausz, T; Pervez, S; Soutter, WP; White, JO	1
Geyer, H; Kleine, W; Maier, T; Pfleiderer, A	1
Mishina, H; Nunokawa, T; Okuyama, S	1
Fujimoto, J; Fujita, H; Hosoda, S; Okada, H	1
Berman, ML; DiSaia, PJ; Mannel, RS; Rettenmaier, MA; Stratton, JA	1
Bonhomme, MG; Fortney, JA; Irwin, KL; Lee, NC; Oberle, MW; Rosero-Bixby, L; Whatley, AS	1
Barnhill, D; Dames, J; Gallup, D; Heller, P; Hoskins, W; Park, R	1

Trials

1 trial(s) available for medroxyprogesterone acetate and Carcinoma, Epidermoid

Article	Year
Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Contraception, 1992, Volume: 45, Issue:4 Topics: Adult; Age Factors; Carcinoma, Squamous Cell; Case-Control Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Invasiveness; Risk; Risk Factors; Sexual Behavior; Smoking; Time Factors; Uterine Cervical Neoplasms	1992

Article

Year

Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.

Contraception, 1992, Volume: 45, Issue:4

Topics: Adult; Age Factors; Carcinoma, Squamous Cell; Case-Control Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Invasiveness; Risk; Risk Factors; Sexual Behavior; Smoking; Time Factors; Uterine Cervical Neoplasms

1992

Other Studies

8 other study(ies) available for medroxyprogesterone acetate and Carcinoma, Epidermoid

Article	Year
Progesterone signaling inhibits cervical carcinogenesis in mice. The American journal of pathology, 2013, Volume: 183, Issue:5 Topics: Animals; Carcinogenesis; Carcinoma, Squamous Cell; Cell Differentiation; Cell Proliferation; Cervix Uteri; Epithelial Cells; Epithelium; Estrogen Receptor alpha; Female; Humans; Medroxyprogesterone Acetate; Mice; Mice, Transgenic; Mucins; Papillomavirus E7 Proteins; Progesterone; Receptors, Progesterone; Signal Transduction; Uterine Cervical Neoplasms	2013
The human squamous cervical carcinoma cell line, HOG-1, is responsive to steroid hormones. International journal of cancer, 1992, Sep-09, Volume: 52, Issue:2 Topics: Adult; Carcinoma, Squamous Cell; Cell Division; Culture Media; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Tamoxifen; Tumor Cells, Cultured; Uterine Cervical Neoplasms	1992
Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance. Gynecologic oncology, 1990, Volume: 38, Issue:1 Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Papillary; Carcinoma, Squamous Cell; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Multivariate Analysis; Neoplasm Invasiveness; Receptors, Estrogen; Receptors, Progesterone; Sarcoma; Survival Analysis; Uterine Neoplasms	1990
Medroxyprogesterone acetate for lung cancer. The Tohoku journal of experimental medicine, 1990, Volume: 161, Issue:2 Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Humans; Lung Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Radiography	1990
Inhibition of tumor angiogenesis activity by medroxyprogesterone acetate in gynecologic malignant tumors. Invasion & metastasis, 1989, Volume: 9, Issue:5 Topics: Adenocarcinoma; Angiogenesis Inducing Agents; Carcinoma, Squamous Cell; Cell Division; Cystadenocarcinoma; Female; Fibroblast Growth Factors; Genital Neoplasms, Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neovascularization, Pathologic; Tumor Cells, Cultured; Tumor Stem Cell Assay	1989
Treatment of advanced and recurrent endometrial carcinoma: correlation of patient response to hormonal and cytotoxic chemotherapy and the response predicted by the subrenal capsule chemosensitivity assay. Gynecologic oncology, 1989, Volume: 32, Issue:1 Topics: Actuarial Analysis; Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Evaluation Studies as Topic; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Subrenal Capsule Assay; Uterine Neoplasms	1989
Cervical cancer risk and use of depot-medroxyprogesterone acetate in Costa Rica. International journal of epidemiology, 1988, Volume: 17, Issue:4 Topics: Adult; Carcinoma in Situ; Carcinoma, Squamous Cell; Contraceptive Agents, Female; Costa Rica; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Regression Analysis; Risk Factors; Uterine Cervical Neoplasms	1988
Persistence of endometrial activity after radiation therapy for cervical carcinoma. Obstetrics and gynecology, 1985, Volume: 66, Issue:6 Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; Dilatation and Curettage; Endometrium; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Hyperplasia; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovariectomy; Radiotherapy; Radiotherapy Dosage; Risk; Uterine Cervical Neoplasms; Uterine Hemorrhage; Uterine Neoplasms	1985